Company / Return on Equity (ROE)
iRhythm Holdings, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-29.2%
FY2025
5-year range
-124.6% / -29.2%
FY2021-FY2025
Trend
+76.6%
vs FY2024
Sector context
#127 of 147
Health Care
What the data says
iRhythm Holdings, Inc. reports negative total equity of -29.2% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-29.2% in FY2025 with a 5-year CAGR of -16.3%.
Improved from -58.7% to -29.2% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +19.3pp
- 5-Year Change
- -16.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 147This company -29.2% Sector average -3.0%
▼
-858.9% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 76.6% year-over-year.
- Currently 26.1pp below the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- Negative profit margin: -19.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -29.2% | +76.6% |
| FY2024 | -124.6% | -112.2% |
| FY2023 | -58.7% | -21.3% |
| FY2022 | -48.4% | -33.6% |
| FY2021 | -36.3% | -182.6% |
| FY2020 | -12.8% | +68.2% |
| FY2019 | -40.3% | +58.3% |
| FY2018 | -96.6% | -157.8% |
| FY2017 | -37.5% | -66.8% |
| FY2016 | -22.5% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026